Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Dec;60(6):919–924. doi: 10.1038/bjc.1989.390

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.

J M Morrison 1, A Howell 1, K A Kelly 1, R J Grieve 1, I J Monypenny 1, R A Walker 1, J A Waterhouse 1
PMCID: PMC2247283  PMID: 2690914

Abstract

The aim of this study was to test the effectiveness of a regimen of combination chemotherapy when given as an adjuvant treatment after mastectomy to patients with histologically negative axillary lymph nodes. A total of 574 patients with cancer of the breast and no involvement of axillary lymph nodes were randomised, after simple mastectomy with axillary sampling, to receive either no adjuvant treatment or oral fluorouracil 500 mg, methotrexate 25 mg and chlorambucil 10 mg p.o. on day 1 and fluorouracil 500 mg and chlorambucil 10 mg p.o. on day 2 (LMF) every 21 days for eight cycles. Randomisation was stratified according to menopausal status and tumour size. Treatment was started within 14 days of surgery in 97% of patients. Ninety per cent of patients received eight cycles of chemotherapy with no dose reduction. At a median follow-up of 7 years, there was no evidence that relapse-free or overall survival time were influenced by treatment.

Full text

PDF
919

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Elston C. W., Gresham G. A., Rao G. S., Zebro T., Haybittle J. L., Houghton J., Kearney G. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer. 1982 May;45(5):655–669. doi: 10.1038/bjc.1982.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fisher B., Redmond C., Dimitrov N. V., Bowman D., Legault-Poisson S., Wickerham D. L., Wolmark N., Fisher E. R., Margolese R., Sutherland C. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. doi: 10.1056/NEJM198902233200801. [DOI] [PubMed] [Google Scholar]
  4. Forrest A. P., Roberts M. M., Cant E., Shivas A. Simple mastectomy and pectoral node biopsy. Br J Surg. 1976 Aug;63(8):569–575. doi: 10.1002/bjs.1800630802. [DOI] [PubMed] [Google Scholar]
  5. Friedman M. A., Dorr F. A., Perloff M. Adjuvant therapy for breast cancer patients with negative lymph nodes. NCI Monogr. 1986;(1):139–144. [PubMed] [Google Scholar]
  6. Koyama H., Wada T., Takahashi Y., Nishizawa Y., Iwanaga T., Aoki Y., Terasawa T., Kosaki G., Kajita A., Wada A. Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer. Cancer. 1980 Dec 1;46(11):2373–2379. doi: 10.1002/1097-0142(19801201)46:11<2373::aid-cncr2820461112>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803. [DOI] [PubMed] [Google Scholar]
  8. McGuire W. L., DeLaGarza M. Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J Clin Endocrinol Metab. 1973 Dec;37(6):986–989. doi: 10.1210/jcem-37-6-986. [DOI] [PubMed] [Google Scholar]
  9. Nissen-Meyer R., Høst H., Kjellgren K., Månsson B., Norin T. Treatment of node-negative breast cancer patients with short course of chemotherapy immediately after surgery. NCI Monogr. 1986;(1):125–128. [PubMed] [Google Scholar]
  10. Semiglazov V. F., Bavli J. L., Moiseyenko V. M., Rzhankov S. V., Migmanova N. S., Popova R. T., Seleznyov I. K., Kremen B. V., Kostetskaya T. V., Barash N. J. Clinical trials on adjuvant chemotherapy for breast cancer. Cancer. 1986 May 15;57(10):1957–1960. doi: 10.1002/1097-0142(19860515)57:10<1957::aid-cncr2820571012>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  11. Senn H. J., Jungi W. F., Amgwerd R., Hochuli E., Ammann J., Engelhart G., Heinz C., Wick A., Enderlin F., Creux G. Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results. NCI Monogr. 1986;(1):129–134. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES